Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The hepatocellular calcium-linked exocytosis machinery is a complex system of proteins responsible for the regulated secretion of bile acids, proteins, and lipids from hepatocytes into the bile canaliculi or the bloodstream [PMID: 11514514]. This process is primarily triggered by increases in intracellular calcium concentrations ([Ca2+]i), often mediated by inositol 1,4,5-trisphosphate (IP3) receptors and purinergic signaling [PMID: 7513305]. Key molecular components include SNARE proteins such as Syntaxin 2, SNAP-23, and VAMP8, which facilitate membrane fusion, as well as calcium sensors like Synaptotagmin VII [PMID: 17606460]. Dysregulation of this machinery is a hallmark of various liver diseases, particularly cholestasis, where impaired exocytosis leads to the toxic accumulation of bile acids within hepatocytes [PMID: 12851210]. Therapeutic agents like ursodeoxycholic acid (UDCA) are known to stimulate this machinery by enhancing calcium signaling, thereby promoting biliary secretion and providing hepatoprotection [PMID: 8381124]. Because this term describes a multi-protein physiological process rather than a single molecular entity, it is classified as a machinery or pathway rather than a discrete therapeutic target.
Modulation of intracellular calcium transients and activation of calcium-sensitive proteins (e.g., Synaptotagmin VII) to promote the assembly of SNARE complexes and subsequent vesicle fusion with the canalicular membrane.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatocellular calcium-linked exocytosis machinery.